Comparing Survival Outcomes and Costs Associated With Radical Cystectomy and Trimodal Therapy for Older Adults With Muscle-Invasive Bladder Cancer
Author(s) -
Stephen B. Williams,
Yong Shan,
Usama Jazzar,
Hemalkumar B. Mehta,
Jacques Baillargeon,
Jinhai Huo,
Anthony J. Senagore,
Eduardo Orihuela,
Douglas S. Tyler,
Todd A. Swanson,
Ashish M. Kamat
Publication year - 2018
Publication title -
jama surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.757
H-Index - 176
eISSN - 2168-6262
pISSN - 2168-6254
DOI - 10.1001/jamasurg.2018.1680
Subject(s) - medicine , cystectomy , bladder cancer , radiation therapy , proportional hazards model , surveillance, epidemiology, and end results , cancer registry , propensity score matching , retrospective cohort study , population , cancer , surgery , environmental health
Radical cystectomy is the guidelines-recommended treatment of muscle-invasive bladder cancer, but a resurgence of trimodal therapy has occurred. Limited comparative data are available on outcomes and costs attributable to these 2 treatments.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom